(Q35922431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

W. Martin Kast

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

2

W Martin Kast

1 reference

11 August 2017

Mary A Markiewicz

1

1 reference

11 August 2017

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

417-434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

The dendritic cell system and its role in immunogenicity

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Phagocytosis of antigens by Langerhans cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Immunodominance and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Progress in cancer vaccines by enhanced self-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Differentiation of human dendritic cells from monocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Origin, maturation and antigen presenting function of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Active immunization against cancer with dendritic cells: the near future

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

CD4+ T cell matters in tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Follow-up evaluation of a phase II prostate cancer vaccine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

The biochemistry and cell biology of antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Vaccines against intracellular infections requiring cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029072

21 January 2018

Identifiers

DOI

10.1081/CNV-200029072

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15493363%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference